Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of...

Results from the ELSPIRE study will be presented as late-breaking data at The Liver Meeting® 2026 and simultaneously published in AASLD’s flagship journal, HEPATOLOGYAt Week 52, 85.3% of patients...